Artificial Intelligence Improves Diagnostic Accuracy in Clinical Breast Pathology: A Comprehensive Review
核心洞察
AI is reshaping breast pathology through deep learning and whole-slide imaging, enabling detection of lymph node metastases, Nottingham grading, and biomarker quantification.
Key AI concepts including machine learning, neural networks, and multimodal foundational models are now being applied across multiple diagnostic domains in breast cancer (搜索).
Explainable and interpretable AI systems are essential for clinical adoption, with challenges remaining in data quality, bias, regulatory considerations, and workflow integration.
Artificial intelligence is increasingly reshaping diagnostic pathology, with breast pathology representing one of the most advanced and clinically impactful areas of adoption. Despite rapid progress, many practicing pathologists remain unfamiliar with core AI concepts and their practical implications. A new review published in the field provides a concise and accessible overview of AI in breast pathology, focusing on foundational principles, current clinical applications, and future directions.
Breast cancer (搜索) is a biologically heterogeneous disease in which genomic complexity, dynamic tumor evolution, and variable therapeutic response continue to challenge early detection, prognostication, and treatment selection. Recent advances in artificial intelligence have created new opportunities to integrate high-dimensional genomic, transcriptomic, epigenomic, pathological, radiological, and clinical data into more precise and scalable diagnostic and predictive models.
Foundational AI Concepts in Pathology
The review introduces key AI concepts to establish a common framework for pathologists, including algorithms, models, architectures, machine learning, deep learning, neural networks, and multimodal and foundational models. Important distinctions among generative, black-box, and explainable AI are highlighted, emphasizing the need for transparency and interpretability in clinical settings. As the authors note, these distinctions are critical for ensuring that AI tools are not only accurate but also clinically actionable.
Evolution from Rule-Based Systems to Deep Learning
The evolution of AI in breast pathology is traced from early rule-based computer-assisted diagnostic systems to modern deep learning approaches that leverage large-scale whole-slide imaging datasets. This progression reflects broader trends in computational pathology, where data-driven oncology continues to expand and there remains a need for rigorous and biologically informed computational models that are transparent, generalizable, and clinically actionable.
Current Clinical Applications
Current applications of AI in breast pathology span multiple domains. These include detection of lymph node metastases, Nottingham grading, classification of benign and malignant lesions, and automated quantification of critical biomarkers such as estrogen receptor (搜索), progesterone receptor (搜索), and HER2 (搜索). AI-based approaches to prognosis, risk stratification, prediction of treatment response, and analysis of the tumor microenvironment are also being actively developed and evaluated.
Beyond histopathology, emerging research is exploring AI-enabled integration of multi-omics data, predictive modeling using genomic and transcriptomic signatures, computational pathology and radiogenomic correlation, and liquid biopsy analysis using AI-based frameworks for circulating tumor DNA. Federated learning and privacy-preserving AI approaches are also gaining attention for multi-institutional genomic studies.
Implementation Challenges
The review addresses significant challenges associated with real-world implementation of AI in breast pathology. These include data quality, bias, regulatory considerations, cost, infrastructure, and workflow integration. External validation, reproducibility, bias mitigation, and model robustness remain critical priorities for the field. As data-driven oncology continues to mature, there is a recognized need for computational models that are not only accurate but also transparent, generalizable, and clinically actionable.
Future Directions
Looking forward, the field is moving toward explainable, interpretable, and clinically actionable AI systems. Research priorities include bridging computational innovation with translational and clinical relevance, developing diagnostic algorithms for screening and early detection, and creating models for prognosis, recurrence risk, metastasis prediction, and therapeutic response. The integration of large language models and foundational models that improve the interpretation of breast cancer (搜索) biology represents a particularly promising frontier.